All blog posts
Total 8 results for
Showing 8 out of 8 results
21 November 2022
Emma And Rebekah Talk IP: COVID-19 vaccines and IP – dissecting the flurry of recent patent lawsuits
06 May 2020
Update on medicines and medical devices regulation in the EU and the UK and the impact of COVID-19
30 April 2020
COVID-19: Pressure Points: Supply Chain Difficulties – new global guide, including IP, advertising and collaboration issues
08 April 2020
COVID-19: PRESSURE POINTS: Order SND/326/2020, of 6 April, which establishes special measures to grant prior operating permits for facilities and to use certain medical devices lacking CE certification as a result of the medical crisis linked to the COVID-19 outbreak (Spain)
08 April 2020
COVID-19: Pressure Points: A Catalyst for Collaboration (Global)
03 April 2020
COVID-19: Potential legal impact (latest developments) - Pharma (Spain) (03/04/2020)
19 March 2020
COVID-19: Potential legal impact (latest developments) – Pharma (Spain)
16 March 2020
COVID-19: Potential legal impact - Pharma (Spain)
Showing 8 out of 8 results
Key contacts
Rebekah Gay
Partner, Head of Intellectual Property, Sydney
Laura Orlando
Managing Partner, Milan Office, Milan
Sue Gilchrist
Consultant, Sydney
Peng Lei
Partner, Kewei, Mainland China and Shanghai
Alexandra Neri
Partner, Paris, Korea Group and Africa Group
Dr Ina vom Feld
Partner, Germany
Sebastian Moore
Partner, Head Intellectual Property, London and Milan
Rachel Montagnon
Knowledge Counsel, London